Who is Aramis?

A pioneer in plant-based bioproduction

Based in Quebec City, Canada and founded in 2023, Aramis Biotechnologies operates one of the world’s first commercial plant-based bioproduction facilities in controlled vertical cultivation, transforming each plant into a unit capable of rapidly producing complex proteins and biological molecules at scale.

In 2026, Aramis has more than 80 employees, all shareholders of the company. Together, we are investing in its growth and share the same ambition: to make the plant a full-fledged industrial bioproduction platform, complementary to fermentation and other conventional production methods.

With a proven industrial platform acquired from Medicago and a highly qualified team, Aramis develops and commercializes biosolutions in markets where plants can make a real difference.

Our 2035 vision: to make Aramis the world leader in plant bioproduction and the partner of choice to transform the power of plants into biosolutions on a global scale.